ASH 2015

Epizyme scientists and clinician collaborators presented the following work at the 2015 ASH conference in Orlando, Florida. (Files are in .pdf format)

• Preliminary Report of the Phase 1 Study of the DOT1L Inhibitor Pinometostat (EPZ-5676) in Children with MLL-r Acute Leukemia: Safety, Exposure and Evidence of Target Inhibition

• A Phase 1 Study of the DOT1L Inhibitor Pinometostat (EPZ-5676) in Advanced Leukemia: Safety, Activity and Evidence of Target Inhibition